The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
Issues
Latest issue
Regular issues
Supplements
PCR Trials
All issues
Articles
Regular articles
Ahead of print
All articles
Topics
Coronary interventions
STEMI
NSTEMI
Stable CAD
Stents and scaffolds
Left main and multivessel disease
Bifurcation lesions
CTO
Other coronary interventions
Interventions for valvular disease
TAVI
Mitral valve replacement and repair
Tricuspid / Pulmonary valve
Other valvular and structural interventions
Interventions for heart failure
Acute heart failure
Chronic heart failure
Peripheral interventions
Below the knee
Abdominal aortic aneurysm
Iliac / Femoral / Popliteal
Other peripheral interventions
Interventions for hypertension
Renal artery angioplasty
Renal denervation
Other hypertension
Interventions for stroke
Carotid stenting
LAA closure
Ischaemic stroke
Other stroke interventions
News
Services
Subscribe
Advertise
Reprint-Eprint
Join our mailing list
About
Overview
Editorial board
Rights & permissions
Contact us
Author centre
Philip Urban
Showing 1-11 of 11 articles
Impact of clinical presentation on bleeding risk after percutaneous coronary intervention and implications for the ARC-HBR definition
Gragnano F,
Spirito A,
Corpataux N,
Vaisnora L,
Galea R,
Gargiulo G,
Siontis G,
Praz F,
Lanz J,
Billinger M,
Hunziker L,
Stortecky S,
Pilgrim T,
Bär S,
Ueki Y,
Capodanno D,
Urban P,
Pocock S,
Mehran R,
Heg D,
Windecker S,
Räber L,
Valgimigli M
December 3, 2021 | 10.4244/EIJ-D-21-00181
Drug-coated stents versus bare metal stents in Academic Research Consortium-defined high bleeding risk patients
Marquis-Gravel G,
Urban P,
Copt S,
Capodanno D,
Pocock S,
Sadozai Slama S,
Stoll H,
Tanguay J,
Mehran R,
Leon M,
Rao S,
Morice M,
Krucoff M
June 25, 2021 | 10.4244/EIJ-D-20-00749
Defining the HBR patient – another step in the right direction
Colleran R,
Urban P
August 28, 2020 | 10.4244/EIJV16I5A64
Polymer-free drug-coated stents: workhorse or “niche horse”?
Urban P,
Chevalier B
September 20, 2018 | 10.4244/EIJV14I7A128
Biolimus A9 polymer-free coated stents in high bleeding risk patients undergoing complex PCI: evidence from the LEADERS FREE randomised clinical trial
Lipiecki J,
Brunel P,
Morice M,
Roguelov C,
Walsh S,
Richardt G,
Eerdmans P,
Zambahari R,
Berland J,
Copt S,
Stoll H,
Urban P
July 20, 2018 | 10.4244/EIJ-D-18-00293
Two-year outcomes of high bleeding risk patients with acute coronary syndrome after Biolimus A9 polymer-free drug-coated stents: a LEADERS FREE substudy
Jensen C,
Naber C,
Urban P,
Ong P,
Valdés Chávarri M,
Abizaid A,
Pocock S,
Fabbiocchi F,
Dubois C,
Copt S,
Stoll H,
Morice M
March 20, 2018 | 10.4244/EIJ-D-17-00720
Polymer-free drug-coated coronary stents are cost-effective in patients at high bleeding risk: economic evaluation of the LEADERS FREE trial
Filipovic-Pierucci A,
Durand-Zaleski I,
Butel T,
Greene S,
Hovasse T,
Iñiguez A,
Nazzaro M,
Oldroyd K,
Talwar S,
Richardt G,
Windhovel U,
Urban P,
Morice M
February 20, 2018 | 10.4244/EIJ-D-17-00286
Multivessel versus culprit vessel percutaneous coronary intervention in ST-elevation myocardial infarction: is more worse?
Jaguszewski M,
Radovanovic D,
Nallamothu B,
Lüscher T,
Urban P,
Eberli F,
Bertel O,
Pedrazzini G,
Windecker S,
Jeger R,
Erne P
December 27, 2013 | 10.4244/EIJV9I8A153
Clinical performance of a drug-eluting stent with a biodegradable polymer in an unselected patient population: the NOBORI 2 study
Danzi G,
Chevalier B,
Urban P,
Fath-Ordoubadi F,
Carrié D,
Wiemer M,
Serra A,
Wijns W,
Kala P,
Stabile A,
Ruigomez J,
Sagic D,
Laanmets P,
Strupp G,
West N,
Paunovic D
May 15, 2012 | 10.4244/EIJV8I1A17
Outcomes in patients undergoing multivessel percutaneous coronary intervention using sirolimus-eluting stents: a report from the e-SELECT registry
Cuculi F,
Banning AP,
Abizaid A,
Bartorelli A,
Baux A,
Dzavik V,
Ellis S,
Gao R,
Holmes D,
Jeong M,
Legrand V,
Neumann F,
Nyakern M,
Spaulding C,
Stoll H,
Worthley SG,
Urban P
December 30, 2011 | 10.4244/EIJV7I8A152
A novel ultra-thin bare metal stent (BMS): results from a worldwide registry
Blanchard D,
Danzi G,
Urban P,
Moseri M,
Juergens C,
Guyton R,
Nowak B,
Tresukosol D,
Suttorp MJ,
Farshid A,
Kornowski R,
Garcia E,
Yeend R,
Nagai H,
Paunovic D
August 20, 2007
1
Latest news
AHEAD OF PRINT
Two-year outcomes after TMVR
FREE ARTICLE - Sebastian Ludwig et al
May 26, 2023
Simultaneous Publications at EuroPCR 2023!
May 12, 2023
NEW ISSUE
Debating Invasive Coronary Testing in INOCA Patients; Single Antiplatelet Therapy After PCI; Ultrasound-Guided Femoral Access in the UNIVERSAL Trial
May 12, 2023
AHEAD OF PRINT
BIOSOLVE-IV registry
FREE ARTICLE - Adrian Wlodarczak et al
May 24, 2023
AHEAD OF PRINT EUROPCR
The EURO SHOCK Trial
FREE ARTICLE - Amerjeet Singh Banning et al
May 19, 2023
AHEAD OF PRINT EUROPCR
Early safety and feasibility of a first-in-class biomimetic transcatheter aortic valve (DurAVR)
FREE ARTICLE - Susheel K. Kodali et al
May 19, 2023
AHEAD OF PRINT EUROPCR
TAVI for bicuspid aortic valves with Evolut platform
FREE ARTICLE - Didier Tchétché et al
May 18, 2023
Coronary
Valvular disease
Heart failure
Peripheral
Hypertension
Stroke